Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Share News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,758.00
Bid: 1,750.00
Ask: 1,754.00
Change: 11.00 (0.63%)
Spread: 4.00 (0.229%)
Open: 1,746.00
High: 1,759.00
Low: 1,730.00
Prev. Close: 1,747.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: De La Rue Down As CEO Exits And Profit Falls

Thu, 30th May 2019 10:33

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - LOSERS----------National Grid, down 4.7%, Marks & Spencer, down 4.3%. The stocks went ex-dividend meaning new buyers no longer qualify for the latest payout. ----------Johnson Matthey, down 3.5%. The speciality chemicals firm upped its annual payout following a sharp increase in profit but said growth will be slower next year due to plans for significant investment. "We anticipate that these investments for growth and efficiency will lead to a slightly lower margin than in 2018-19," the company said. Johnson Matthey reported 53% growth in pretax profit to GBP488 million in the financial year that ended on March 31 compared to GBP320 million reported the year earlier, as revenue rose 4.6% to GBP10.75 billion from GBP10.27 billion. Profit was slightly short of market expectations. According to company-compiled consensus figures for financial 2019, pretax profit was expected to jump 56% to GBP500.7 million. Johnson Matthey declared a final dividend of 62.25 pence a share, taking the total payout for the year to 85.5p, up 6.9% from 80.0p paid the year before. Looking ahead, Johnson Matthey said it expects foreign exchange movements in the financial year to the end of March 2020 to hurt sales and underlying operating profit by GBP6 million and GBP2 million, respectively.----------FTSE 250 - WINNERS----------FirstGroup, up 5.5%. The transport operator unveiled a new strategy which will see the sale of the transport operator's North American intercity coach operation, Greyhound, as well as separation of its UK bus business, First Bus. The company said it has started the sale process for Greyhound as the unit has "limited synergies" with the rest of the company's operations. For the same reason, FirstGroup plans to separate First Bus from its UK operations. Going ahead, North America will be the firm's core market with emphasis on First Student and First Transit, which together generated 60% of group operating profit in 2019 and "have the greatest potential to generate sustainable value and growth over time". Separately, the company reported a narrowed pretax loss for the year ended March to GBP97.9 million from GBP326.9 million. Revenue for the year rose 11% to GBP7.13 billion from GBP6.40 billion. Looking ahead, FirstGroup said it expects to deliver revenue growth and financial progress in its Road divisions in financial 2020, with adjusted earnings guided "broadly in line with expectations". Spreadex analyst Connor Campbell said: "Beyond replacing the CEO and board, this basically ticks off most of the demands Coast Capital had been making, and was clearly popular with investors,"----------Tullow Oil, up 3.5%. Goldman Sachs promoted the oil and gas company to its Conviction Buy List.----------FTSE 250 - LOSERS----------Computacenter, down 1.7%. The stock went ex-dividend.----------Babcock International, down 1.6%. Goldman Sachs downgraded the engineering services firm to Neutral from Conviction Buy. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Nuformix, up 37%. The pharmaceutical development company reported positive results in its clinical study of NXP001. The company explained that NXP001 is being developed as a treatment for chemotherapy-induced nausea and vomiting, occurring in a third of cancer patients worldwide. In a pilot study conducted among healthy subjects, Nuformix's cocrystal-based formulation demonstrated bioequivalence to Merck's EMEND, the currently used treatment for nausea and vomiting in chemotherapy, both in terms of peak and overall exposure. The positive results allow Nuformix to receive a final GBP2 million milestone payment form its Chinese licensing partner, Newsummit Biopharma, which has started product registration in China.----------BigDish, up 15%. The online reservation platform said it is now ready to start the larger UK roll out of its restaurant reservation app. The company's BigDish app is expected to go live in Brighton and Reading on June 7, following the successful launch in Swindon and Taunton. The app allows restaurant-goers to book a table and receive discounts. As it rolls the service out nationwide, Big Dish has divided the UK into ten territories. Each territory will have one manager with the exception of London, which will have three. BigDish expects the managers recruitment process to take between three and four months. The company now has over 150 restaurants on its platform, most of which independent. It said its roll out plans will initially target independent and smaller restaurant groups. ----------OTHER MAIN MARKET AND AIM - LOSERS----------De La Rue, down 31%. The banknote printer proposed a restructuring, after annual profit fell sharply and in preparation for the expiration of the company's UK passport contract. In addition, De La Rue said Martin Sutherland has agreed to step down as chief executive as soon as his successor is in place. The company has already commenced the recruitment process, it said. Pretax profit for the financial year ended March 30 dropped to GBP25.5 million from GBP113.6 million a year earlier, as operating expenses jumped to GBP533.3 million from GBP370.9 million. De La Rue declared a final dividend of 16.7 pence a share, unchanged from the prior year. This would make a full year payout of 25.0p per share, also unchanged. De La Rue proposed a reorganisation that is aimed at creating better strategic focus and greater efficiency, with a cost-cutting programme that will deliver in excess of GBP20 million annual savings by 2022. De La Rue intends to restructure its operations into two divisions: Authentication and Currency. ----------

More News
11 Nov 2021 09:20

UPDATE 2-Johnson Matthey shares plunge as it exits battery materials business, CEO to step down

* Triple whammy of market exit, CEO change, profit warning hurt co* Names Bayer's Condon to succeed MacLeod* Investments in battery material not justified now - Co (Writes through with detail, shares)By Yadarisa ShabongNov 11 (Reuters) - Johnson Ma...

Read more
11 Nov 2021 09:18

TOP NEWS: Johnson Matthey warns on profit amid restructuring, new CEO

TOP NEWS: Johnson Matthey warns on profit amid restructuring, new CEO

Read more
11 Nov 2021 08:54

LONDON MARKET OPEN: Auto Trader and Johnson Matthey bookend FTSE 100

LONDON MARKET OPEN: Auto Trader and Johnson Matthey bookend FTSE 100

Read more
11 Nov 2021 08:25

LONDON BRIEFING: Johnson Matthey to change CEO and exit battery metals

LONDON BRIEFING: Johnson Matthey to change CEO and exit battery metals

Read more
11 Nov 2021 08:04

Johnson Matthey announces CEO departure, to sell battery materials business

(Sharecast News) - Johnson Matthey announced the departure of its chief executive on Thursday, alongside plans to sell its battery materials business, as it warned the trading outlook for the full year was towards the lower end of market expectations.

Read more
11 Nov 2021 07:52

LONDON MARKET PRE-OPEN: Johnson Matthey to exit Battery Materials

LONDON MARKET PRE-OPEN: Johnson Matthey to exit Battery Materials

Read more
8 Nov 2021 15:23

Johnson Matthey appoints BASF's Giovanzana as MD of Catalyst Technologies

(Sharecast News) - Johnson Matthey said on Monday that it has appointed Alberto Giovanzana as managing director of its catalyst technologies division.

Read more
1 Nov 2021 16:25

EXECUTIVE CHANGES: TP Group CEO out as Science Group tightens grip

EXECUTIVE CHANGES: TP Group CEO out as Science Group tightens grip

Read more
14 Oct 2021 12:46

Jefferies downgrades Johnson Matthey

(Sharecast News) - Jefferies downgraded Johnson Matthey to 'underperform' from 'buy' on Thursday and cut the price target to 2,300p from 4,200p, saying it expects the shares to underperform as the company's automotive catalyst business remains weak.

Read more
14 Oct 2021 09:42

LONDON BROKER RATINGS: Jefferies cuts Johnson Matthey to Underperform

LONDON BROKER RATINGS: Jefferies cuts Johnson Matthey to Underperform

Read more
14 Oct 2021 08:17

LONDON BRIEFING: Mixed China price data after US inflation ticks up

LONDON BRIEFING: Mixed China price data after US inflation ticks up

Read more
13 Oct 2021 09:58

LONDON BROKER RATINGS: UBS cuts Informa to Sell; M&S gets upgrade

LONDON BROKER RATINGS: UBS cuts Informa to Sell; M&S gets upgrade

Read more
13 Oct 2021 09:48

Berenberg lowers target price on Johnson Matthey

(Sharecast News) - Analysts at Berenberg lowered their target price on diversified chemicals group Johnson Matthey from 3,800.0p to 3,600.0p on Wednesday ahead of the firm's interim results next month.

Read more
5 Oct 2021 09:39

LONDON BROKER RATINGS: Investec lifts Virgin Money UK to Buy

LONDON BROKER RATINGS: Investec lifts Virgin Money UK to Buy

Read more
4 Oct 2021 09:26

LONDON BROKER RATINGS: Upgrades for Burberry, Future and Wetherspoon

LONDON BROKER RATINGS: Upgrades for Burberry, Future and Wetherspoon

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.